Last reviewed · How we verify
NCT04111952
The Effect of Additional Laser Treatments.
NA trial testing CO2 laser in Lax Vaginal Introitus in 253 participants. Status unknown.
1 November 2021
Quick facts
| Lead sponsor | Rambam Health Care Campus |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 253 |
| Start date | 1 June 2019 |
| Primary completion | 1 November 2021 |
| Estimated completion | 28 January 2023 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- CO2 laser
- Sham laser
Conditions studied
- Lax Vaginal Introitus — all drugs for Lax Vaginal Introitus →
Sponsor
Rambam Health Care Campus — full company profile →
Who can join
Adults 18 to 70, female only, with Lax Vaginal Introitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Women previously treated with vaginal CO2 laser will receive an additional treatment 6 months after cessation of previous laser treatment or a sham laser treatment. The efficacy and safety of the additional treatment will be assessed.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The efficacy and safety of a single maintenance laser treatment for stress urinary incontinence: a double-blinded randomized controlled trial.
Lauterbach R, Aharoni S, Justman N, Farago N, et al · · 2022 · cited 18× · PMID 35195738 · DOI 10.1007/s00192-022-05103-x
Verify or expand the search:
- PubMed search for NCT04111952
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of CO2 laser
Trials testing the same drug.
- NCT06508788 — Combination of the Vaginal Laser With a Moisturizing and Repairing Niosomal Gel in the Treatment of Genitourinary Syndro · recruiting
- NCT05995626 — Hyaluronidase Via LADD Scleroderma-induced Microstomia · EARLY_PHASE1 · completed
- NCT04575142 — Comparison of Office-based KTP and CO2 Laser Outcomes in Patients With Vocal Cord Lesions. · NA · completed
- NCT05336825 — CO2 Laser vs Lidocaine for Vestibulodynia in Premenopausal Women · NA · completed
- NCT03433664 — Carbon Dioxide Laser Treatment in Burn-related Scarring · NA · completed
Other Rambam Health Care Campus trials
Trials by the same sponsor.
- NCT07384013 — Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs · NA · recruiting
- NCT06688253 — Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis · Phase 4 · not yet recruiting
- NCT06235749 — Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery · NA · recruiting
- NCT06622902 — Influence of Flow Rate Change on CO2 Levels During High Flow Nasal Ventilation (HFNV) in Preterm Infants. · NA · recruiting
- NCT05922111 — Cervical Ripening Balloon for 12 Hours vs. 1 Hour. · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04111952 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rambam Health Care Campus
- Last refreshed: 20 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04111952.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing